NIH-funded research R37 grant

Understanding how a brain-like immune switch (TREM2) affects chronic pancreatitis

Official title: Delineating the role of TREM2 in chronic pancreatitis

Funded at University of Tx Md Anderson Can Ctr · NIH-11269401 · Data updated 2026-11-12

A patient-friendly look at how a specific immune receptor called TREM2 might control inflammation and tissue damage in chronic pancreatitis, with potential paths toward better treatment.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 9, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$374,006
NIH project number1R37CA307597-01
Project IDNIH-11269401 on NIH RePORTER

Who could benefit from this research

Could help

Patients with chronic pancreatitis or those at risk due to pancreatic inflammation and fibrosis.

Less likely to help

People without pancreatic disease or those not contributing tissue samples or participating in related studies may not benefit.

What this research studies

Chronic pancreatitis is a long-lasting inflammatory disease that damages the pancreas. This project focuses on macrophages, immune cells that can both promote and reduce inflammation, and how the TREM2 receptor helps keep them in balance. Researchers will study TREM2’s role in human pancreas tissue and test ideas in lab models to see if boosting TREM2 could lessen inflammation and fibrosis. If successful, the work could point to new therapies that help people manage this condition and protect pancreatic function.

Why it matters

Potential benefit: If successful, the research could lead to new therapies that reduce inflammation and scarring in chronic pancreatitis, potentially easing symptoms and slowing disease progression.

How similar studies have gone: Preliminary data in human CP tissues suggest macrophage balance and TREM2 are linked to inflammatory signaling, indicating potential for a targeted approach.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Chen, Yang — University of Tx Md Anderson Can Ctr
  • Study coordinator: Chen, Yang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.